CClinicalTrials.gg
CompletedNCT00564317Updated Nov 27, 2007

KIDNET vs Meditation/Relaxation - a Dissemination Randomized Controlled Trial for the Treatment of Traumatized Children After War in Sri Lanka

A Phase 3 interventional study of KIDNET and Meditation/Relaxation in Post-Traumatic Stress Disorders, sponsored by University of Konstanz. Completed at 1 site in Sri Lanka. Open to participants aged 11 Years to 15 Years. Per ClinicalTrials.gov, last updated 2007-11-27.

Sponsored by University of Konstanz · Phase 3, Interventional, and Treatment

Phase
Phase 3
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
11 Years to 15 Years
Sex
All
01

Study summary

The purpose of this study is to assess the efficacy of KIDNET versus a Meditation/Relaxation protocol in treating traumatized children when applied by locally trained teacher counsellors as well as the effectiveness and adequacy of such a treatment in a south-asian war affected stayee child community.

Read the detailed description

Outcome measures include PTSD symptom score, Depression score, Suicidal ideation and related functioning measures (including school grades)

02

Conditions studied

  • Post-Traumatic Stress Disorders

Keywords

  • PTSD
  • Depression
  • Suicidality
  • trauma-focussed treatment
  • KIDNET
  • Narrative Exposure Therapy for Children
  • Meditation
  • Relaxation
  • War
03

In context

Stress Disorders, Traumatic

1,147 studies on the registry are indexed under Stress Disorders, Traumatic; 108 are open to participants now.

This study's enrollment of 48 is below the median of 60 across 908 interventional studies indexed under Stress Disorders, Traumatic.

Browse Stress Disorders, Traumatic studies →

Lead sponsor

University of Konstanz is the lead sponsor of 48 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • all children with PTSD Diagnosis from six surveyed schools in Vallikamam/Jaffna educational zones age range 11-15

Exclusion criteria

Exclusion Criteria:

  • none
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
48 participants (actual)

Study arms

  • Experimental
    1 KIDNET

    Narrative Exposure Therapy for Children

    Behavioral: KIDNET

  • Experimental
    2 Meditation/Relaxation

    mixed Meditation/Relaxation Protocol

    Behavioral: Meditation/Relaxation

  • Experimental
    3 KIDNET + Meditation/Relaxation

    KIDNET according to protocol, waiting time of 5 months, then Meditation/Relaxation according to protocol

    Behavioral: KIDNET · Behavioral: Meditation/Relaxation

  • Experimental
    4 Meditation/Relaxation + KIDNET

    Med/Relax according to protocol, 5 months waiting time, KIDNET according to protocol

    Behavioral: KIDNET · Behavioral: Meditation/Relaxation

Interventions

  • BehavioralKIDNET

    Narrative Exposure Therapy for Children - a short term intervention for the treatment of trauma after war, organized violence, torture, abuse and other detrimental life events

  • BehavioralMeditation/Relaxation

    a protocol of traditional/local meditation and relaxation exercises, such as breathing meditation, chanting, body relaxation

06

What researchers measure

Primary outcomes

  1. PTSD-Symptoms according to CAPS-CA (DSM-IV)

    Time frame: pre-test, 5-months, 14-months

Secondary outcomes

  1. Depression score & Suicidality according to M.I.N.I. KID A and B

    Time frame: pre-test, 5-months, 14-months

07

Study locations

1 site
  • University of Konstanz/vivo e.V. Germany & Vallikamam/Jaffna Educational Zones, Sri Lanka
    Jaffna/Vallikamam, Sri Lanka
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 27, 2007, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00564317
Lead sponsor
University of Konstanz
Collaborators
NGO vivo e.V., GTZ-German Technical Cooperation, Germany, European Refugee Fund, German Research Foundation
First posted
Nov 27, 2007
Start date
Sep 2004
Completion
Jan 2006
Last update
Nov 27, 2007

Study contacts

Brigitte Rockstroh, Prof Dr
principal investigator · University of Konstanz
Elisabeth Schauer, MA/MPH
principal investigator · University of Konstanz

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2007. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion